CA2031199A1 - Peptides antibacteriens et anti-malaria - Google Patents

Peptides antibacteriens et anti-malaria

Info

Publication number
CA2031199A1
CA2031199A1 CA2031199A CA2031199A CA2031199A1 CA 2031199 A1 CA2031199 A1 CA 2031199A1 CA 2031199 A CA2031199 A CA 2031199A CA 2031199 A CA2031199 A CA 2031199A CA 2031199 A1 CA2031199 A1 CA 2031199A1
Authority
CA
Canada
Prior art keywords
peptides
antimalarial
antibacterial
antibiotically
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2031199A
Other languages
English (en)
Other versions
CA2031199C (fr
Inventor
Robert Bruce Merrifield
Hans G. Boman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rockefeller University
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2031199A1 publication Critical patent/CA2031199A1/fr
Application granted granted Critical
Publication of CA2031199C publication Critical patent/CA2031199C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Insects & Arthropods (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

On prépare des peptides hybrides présentant une activité antibiotique et/ou antipaludéenne, contenant environ 20 à environ 40 résidus d'acides aminés, par redisposition de séquences sélectionnées de peptides connus.
CA002031199A 1989-04-12 1990-04-12 Peptides antibacteriens et anti-malaria Expired - Fee Related CA2031199C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US33677789A 1989-04-12 1989-04-12
US336,777 1989-04-12
US44959389A 1989-12-12 1989-12-12
US449,593 1989-12-12
PCT/US1990/002082 WO1990011771A1 (fr) 1989-04-12 1990-04-12 Peptides antibacteriens et antipaludeens

Publications (2)

Publication Number Publication Date
CA2031199A1 true CA2031199A1 (fr) 1990-10-13
CA2031199C CA2031199C (fr) 2000-08-22

Family

ID=26990366

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002031199A Expired - Fee Related CA2031199C (fr) 1989-04-12 1990-04-12 Peptides antibacteriens et anti-malaria

Country Status (7)

Country Link
EP (1) EP0422215B1 (fr)
JP (1) JPH0730120B2 (fr)
AT (1) ATE169824T1 (fr)
CA (1) CA2031199C (fr)
DE (1) DE69032574T2 (fr)
DK (1) DK0422215T3 (fr)
WO (1) WO1990011771A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117069819A (zh) * 2023-09-13 2023-11-17 南华大学 一种黑腹狼蛛抗菌肽lc-amp-i1及其应用

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792831A (en) * 1990-02-08 1998-08-11 Magainin Pharmaceuticals Inc. Analogues of magainin peptides containing D-amino acids
WO1993024636A1 (fr) * 1992-05-29 1993-12-09 The University Of British Columbia Emploi de la proteine oprf dans l'expression d'oligopeptides a la surface de cellules bacteriennes
US5607914A (en) * 1993-01-13 1997-03-04 Pioneer Hi-Bred International, Inc. Synthetic antimicrobial peptides
US5580852A (en) * 1993-12-17 1996-12-03 Pioneer Hi-Bred International, Inc. Derivatives of tachyplesin having inhibitory activity towards plant pathogenic fungi
GB0821687D0 (en) 2008-11-28 2008-12-31 Secr Defence Peptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4520016A (en) * 1980-06-17 1985-05-28 Kabigen Ab Bacteriolytic proteins
US4355104A (en) * 1980-06-17 1982-10-19 Kabigen Ab Bacteriolytic proteins
JPS6360939A (ja) * 1986-08-29 1988-03-17 Shin Etsu Chem Co Ltd 抗菌物質

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117069819A (zh) * 2023-09-13 2023-11-17 南华大学 一种黑腹狼蛛抗菌肽lc-amp-i1及其应用
CN117069819B (zh) * 2023-09-13 2024-03-19 南华大学 一种黑腹狼蛛抗菌肽lc-amp-i1及其应用

Also Published As

Publication number Publication date
DE69032574D1 (de) 1998-09-24
DK0422215T3 (da) 1999-05-25
ATE169824T1 (de) 1998-09-15
EP0422215B1 (fr) 1998-08-19
WO1990011771A1 (fr) 1990-10-18
EP0422215A1 (fr) 1991-04-17
JPH0730120B2 (ja) 1995-04-05
JPH03501742A (ja) 1991-04-18
EP0422215A4 (en) 1992-05-20
CA2031199C (fr) 2000-08-22
DE69032574T2 (de) 1999-04-29

Similar Documents

Publication Publication Date Title
EP1440980A3 (fr) Analogues peptidiques de la protéine basique de la myéline humaine
AU1179795A (en) Improved immunogenic compositions against human gastrin 17
AU7607091A (en) Improved retainer for surgical sutures
AU7126281A (en) N-(vinblastinoyl-23)derivatives of amino acid and peptides
IL108892A0 (en) Aza cyclohexapeptide compounds and antimicrobial compositions containing them
ATE108662T1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
CA2063063A1 (fr) Peptide antimicrobien et agent antimicrobien
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
WO1996028470A3 (fr) Analogues peptidiques de proteine de base de myeline utile dans le traitement de la sclerose en plaques
AU2711988A (en) Articles for tissue contact containing an antimicrobial agent
AU6963391A (en) Amino acid protecting groups
EP0494248A4 (en) Anti-thrombotic peptides and pseudopeptides
CA2111340A1 (fr) Nouveaux polypeptides et utilisation
GR880300151T1 (en) Derivative of thiazolidine-4-carboxylic acid, its preparation and pharmaceutical compositions containing it
AU613228B2 (en) A new antibiotic, mersacidin, a process for the preparation thereof and the use thereof as a pharmaceutical
IE902388L (en) Vasoactive intestinal peptide analogs.
CA2031199A1 (fr) Peptides antibacteriens et anti-malaria
AU634280B2 (en) Anticoagulant peptides
AU610900B2 (en) Immunosuppressant peptides
AU5407190A (en) Peptides having novel polar n-terminal groups
CA2004885A1 (fr) Peptides anticoagulant
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
AU4410989A (en) Cpf peptide compositions and uses
CA2171953A1 (fr) Analogues de regulateurs de proteines du complement d'activation
AU9038491A (en) Lyophilized amino acid compositions containing glutamine

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed